首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Effect of Korean Herbal Medicine Combined with a Probiotic Mixture on Diarrhea-Dominant Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial
【24h】

Effect of Korean Herbal Medicine Combined with a Probiotic Mixture on Diarrhea-Dominant Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial

机译:韩国草药结合益生菌混合物对腹泻型肠易激综合征的影响:双盲,随机,安慰剂对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction. Although combination therapy with herbal medicine and probiotics is gaining popularity for controlling diarrhea-dominant irritable bowel syndrome (D-IBS) symptoms, few studies have investigated its clinical effects. Materials and Methods. Fifty-three patients with D-IBS were randomly allocated into 1 of the following 4 groups: herbal medicine {Gwakhyangjeonggisan; GJS) plus probiotics (Duolac7S; DUO), GJS plus placebo DUO, placebo GJS plus DUO, and placebo GJS plus placebo DUO. The study period consisted of a 2-week run-in, 8 weeks of administration, and 2 weeks of follow-up. The primary outcomes were weekly adequate relief (AR) of overall IBS symptoms and the proportion of responders (PR) during the administration period. The secondary outcomes included individual IBS symptoms, stool assessment, and quality of life. Changes of intestinal microbiota and intestinal permeability were also analyzed. Results and Discussion. Weekly AR was not different among the 4 groups throughout the treatment period. However, the 3 treatment groups exhibited significant improvements in PR compared to the findings in the placebo group. In the intestinal microbiota assessment, herbal medicine and probiotics synergistically increased beneficial bacteria counts. Conclusion. Combination therapy with herbal medicine and probiotics appears to relieve overall IBS symptoms by synergistically increasing beneficial intestinal microbe counts.
机译:介绍。尽管结合草药和益生菌的联合疗法在控制腹泻为主的肠易激综合症(D-IBS)症状方面正变得越来越流行,但很少有研究调查其临床效果。材料和方法。 53例D-IBS患者被随机分为以下4组中的1组:草药{Gwakhyangjeonggisan; GJS)和益生菌(Duolac7S; DUO),GJS和安慰剂DUO,安慰剂GJS和DUO,以及安慰剂GJS和安慰剂DUO。研究期包括2周的磨合,8周的给药和2周的随访。主要结局是在给药期间每周全面缓解IBS总体症状(AR)和缓解者比例(PR)。次要结果包括个别IBS症状,粪便评估和生活质量。还分析了肠道菌群和肠道通透性的变化。结果与讨论。在整个治疗期间,这4组之间的每周AR并无差异。但是,与安慰剂组相比,这3个治疗组的PR均有显着改善。在肠道菌群评估中,草药和益生菌可协同增加有益细菌的数量。结论。草药和益生菌的联合治疗似乎可通过协同增加有益的肠道微生物数量来缓解整体IBS症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号